27.09.2014 Views

Program - Society of Toxicology

Program - Society of Toxicology

Program - Society of Toxicology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Society</strong> <strong>of</strong> <strong>Toxicology</strong> 2011<br />

Continuing Education (Continued)<br />

Today toxicologists must select appropriate model organisms, manage<br />

abundant high-throughput data, understand legacy data, and develop<br />

pathway-based understanding <strong>of</strong> environmental factors influencing<br />

biological systems. Mastery <strong>of</strong> these concepts improves toxicity prediction<br />

while providing insights into environmentally influenced diseases<br />

and phenotypes. A clear understanding <strong>of</strong> the diverse on-line data resource<br />

aims and limitations equips the researcher with the best combination <strong>of</strong><br />

resources to effectively address their questions.<br />

• Reactome Knowledgebase, Marc E. Gillespie, St. Johns University,<br />

Jamaica, NY<br />

• Comparative Toxicogenomics Database (CTD), Carolyn J.<br />

Mattingly, Mount Desert Island Biological Laboratory, Salisbury Cove,<br />

ME<br />

• PharmGKB, Teri E. Klein and Li Gong, Stanford University Medical<br />

Center, Stanford, CA<br />

• Mouse Genome Informatics Database, Susan M. Bello, Jackson<br />

Laboratory, Bar Harbor, ME<br />

Sunday Morning, March 6<br />

8:15 AM to 12:00 NOON<br />

First and Second Level (See signage at CE Booths for room<br />

locations)<br />

Epigenetic Mechanisms<br />

Epigenetics in <strong>Toxicology</strong>: Introduction, Mechanistic<br />

Understanding, and Applications in Safety Assessment<br />

AM05<br />

CE Basic<br />

Chairperson(s): Mayurranjan S. Mitra, Washington University School <strong>of</strong><br />

Medicine, St. Louis, MO, and Thomas Sussan, Johns Hopkins University<br />

Bloomberg School <strong>of</strong> Public Health, Baltimore, MD.<br />

Sponsor:<br />

Molecular Biology Specialty Section<br />

Endorsed by:<br />

Carcinogenesis Specialty Section<br />

Cardiovascular <strong>Toxicology</strong> Specialty Section<br />

Mechanisms Specialty Section<br />

Epigenetics refers to molecular mechanisms that cause heritable changes<br />

in gene expression without altering the DNA sequence. The most<br />

widely studied epigenetic mechanisms encompass DNA methylation,<br />

histone modifications, and gene regulation by non-coding RNAs, such<br />

as microRNAs. Typically, these mechanisms are required for normal<br />

cellular development and differentiation; however, perturbations in<br />

them can lead to diseases, notably cancer. Increasing evidence suggest<br />

that environmental factors such as diet, stress, and exposure to radiation<br />

and xenobiotics can induce heritable changes in the epigenetic status,<br />

potentially affecting the health <strong>of</strong> the present and future generations.<br />

Importantly, the long-term and life-threatening consequences <strong>of</strong> environment/chemical-induced<br />

changes in epigenetics, makes this field a critical<br />

area for future exploration by toxicologists. The course will begin by<br />

introducing the fundamental concepts <strong>of</strong> epigenetics and reviewing the<br />

various underlying mechanisms. Methods to assess epigenetic changes<br />

will be discussed, followed by a discussion <strong>of</strong> the role <strong>of</strong> DNA cytosine<br />

methylation in the regulation <strong>of</strong> carcinogen-inducible CYP450 genes.<br />

Mechanistic understanding <strong>of</strong> the role <strong>of</strong> microRNAs in the regulation<br />

<strong>of</strong> cellular toxicity and the influence <strong>of</strong> environment on epigenetics that<br />

cause developmental effects will also be presented. Finally, the future <strong>of</strong><br />

epigenetics in toxicology and its potential applications for safety assessment<br />

will be discussed. Students as well as toxicologists working in<br />

academia, federal and pharmaceutical industries, and researchers interested<br />

in mechanistic toxicology will benefit from taking this course.<br />

• Introduction, Mayurranjan S. Mitra, Washington University School <strong>of</strong><br />

Medicine, St. Louis, MO<br />

• Introduction and Overview <strong>of</strong> Epigenetics, James G. Herman, The<br />

Johns Hopkins School <strong>of</strong> Medicine, Baltimore, MD<br />

• Role <strong>of</strong> Epigenetics in the Regulation <strong>of</strong> Carcinogen-Metabolizing<br />

Enzymes, Oliver Hankinson, University <strong>of</strong> California Los Angeles,<br />

Los Angeles, CA<br />

• Retroelements and MicroRNAs in the Epigenetic Regulation <strong>of</strong><br />

Cellular Differentiation, Proliferation, and Toxicity, Kenneth S.<br />

Ramos, University <strong>of</strong> Louisville, Louisville, KY<br />

• Epigenetic Gene Regulation: Linking Early Developmental<br />

Environment to Adult Disease, Dana Dolinoy, University <strong>of</strong><br />

Michigan, Ann Arbor, MI<br />

• What We Need to Know Prior to Incorporating an Epigenetic<br />

Evaluation into Safety Assessments, Jay I. Goodman, Michigan State<br />

University, East Lansing, MI<br />

Sunday Morning, March 6<br />

8:15 AM to 12:00 NOON<br />

First and Second Level (See signage at CE Booths for room<br />

locations)<br />

Integration <strong>of</strong> Toxicological and Epidemiological Evidence<br />

to Understand Human Risk<br />

Protecting Human Health: Use <strong>of</strong> Toxicological and<br />

Epidemiological Data in Determining Safe Levels for Human<br />

Exposure<br />

AM06<br />

CE Basic<br />

Chairperson(s): Eileen P. Hayes, EP Hayes <strong>Toxicology</strong> Services LLC,<br />

Longmont, CO, and Terry Gordon, New York University School <strong>of</strong><br />

Medicine, Tuxedo Park, NY.<br />

Sponsor:<br />

Occupational and Public Health Specialty Section<br />

Toxicological and epidemiological data are the basis for risk assessment<br />

processes used to determine acceptable levels <strong>of</strong> exposure. This is the<br />

case for the general public who may be exposed to pollutants via ambient<br />

air and/or drinking water, for workers who may be exposed to chemicals<br />

in the workplace, and for patients who may have exposure to both active<br />

pharmaceutical ingredients (API) and impurities that may be present in<br />

the product. The goal <strong>of</strong> this course is to provide students with an understanding<br />

<strong>of</strong> the regulatory background and the practical application <strong>of</strong><br />

both toxicological and epidemiological information in setting exposure<br />

levels considered to be protective <strong>of</strong> public health. The objectives <strong>of</strong> this<br />

course are 1) to describe the regulatory requirements that underlie development<br />

<strong>of</strong> acceptable levels <strong>of</strong> exposure for either the general population<br />

or select populations (workers, patients) via the media described above;<br />

and 2) to describe the evaluation <strong>of</strong> toxicological and epidemiological<br />

data in determining acceptable levels <strong>of</strong> exposure. Case studies <strong>of</strong> representative<br />

compounds will illustrate the processes. The U.S. Environmental<br />

Protection Agency (U.S. EPA) has well-defined processes for establishing<br />

both National Ambient Air Quality Standards (NAAQS) under the Clean<br />

Air Act and drinking water Maximum Contaminant Levels (MCLs) under<br />

the Safe Drinking Water Act. The Occupational Health and Safety Administration<br />

(OSHA) promulgates permissible exposure limits (PELs) for the<br />

workplace. The American Conference <strong>of</strong> Government Industrial Hygienists<br />

(ACGIH), a nonpr<strong>of</strong>it, non-governmental organization publishes<br />

Threshold Limit Values (TLVs) that are used globally by many public and<br />

private-sector employers to protect the health <strong>of</strong> their employees. Additionally,<br />

many employers have established programs to derive acceptable<br />

levels <strong>of</strong> workplace exposure for compounds not specifically regulated<br />

by government agencies. Acceptable identification, reporting, and safety<br />

thresholds for impurities in drug products are governed under guidance<br />

CE<br />

up-to-date information at www.toxicology.org<br />

91

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!